Drug Information

Drug General Information
Drug ID
D0Q1UB
Former ID
DIB005680
Drug Name
GZ402666
Indication Pompe's disease [ICD10:E74.02] Phase 1 [524362]
Target and Pathway
Target(s) Lysosomal alpha-glucosidase Target Info Modulator [524362]
KEGG Pathway Galactose metabolism
Starch and sucrose metabolism
Metabolic pathways
Lysosome
Pathway Interaction Database Notch-mediated HES/HEY network
PathWhiz Pathway Galactose Metabolism
References
Ref 524362ClinicalTrials.gov (NCT01898364) Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.. U.S. National Institutes of Health.
Ref 524362ClinicalTrials.gov (NCT01898364) Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.